Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age
American Journal of Obstetrics and Gynecology · 2024-03 · 230 (3) · 368.e1-368.e12
DOI: 10.1016/j.ajog.2023.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Obstetrics and Gynecology, 2024-03. Verfasst von Lindsay R Freud und 59 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Sick Children, University of Toronto, Toronto, Canada. Electronic address: lindsay.freud@sickkids.ca. Hauptthemen laut MEDLINE: DiGeorge Syndrome, Heart Defects, Congenital. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NICHD NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The 22q11.2 deletion syndrome is the most common microdeletion syndrome and is frequently associated with congenital heart disease. Prenatal diagnosis of 22q11.2 deletion syndrome is increasingly offered. It is unknown whether there is a clinical benefit to prenatal detection as compared with postnatal diagnosis. OBJECTIVE: This study aimed to determine differences in perinatal and infant outcomes between patients with prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. STUDY DESIGN: This was a retrospective cohort study across multiple international centers (30 sites, 4 continents) from 2006 to 2019. Participants were fetuses, neonates, or infants with a genetic diagnosis of 22q11.2 deletion syndrome by 1 year of age with or without congenital heart disease; those with prenatal diagnosis or suspicion (suggestive ultrasound findings and/or high-risk cell-free fetal DNA screen for 22q11.2 deletion syndrome with postnatal confirmation) were compared with those with postnatal diagnosis. Perinatal management, cardiac and noncardiac morbidity, and mortality by 1 year were assessed. Outcomes were adjusted for presence of critical congenital heart disease, gestational age at birth, and site. RESULTS: A total of 625 fetuses, neonates, or infants with 22q11.2 deletion syndrome (53.4% male) were included: 259 fetuses were prenatally diagnosed (156 [60.2%] were live-born) and 122 neonates were prenatally suspected with postnatal confirmation, whereas 244 infants were postnatally diagnosed. In the live-born cohort (n=522), 1-year mortality was 5.9%, which did not differ between groups but differed by the presence of critical congenital heart disease (hazard ratio, 4.18; 95% confidence interval, 1.56-11.18; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital for Sick Children, University of Toronto, Toronto, Canada. Electronic address: lindsay.freud@sickkids.ca.
- NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York City, NY.
- Children's Hospital of Philadelphia, Philadelphia, PA.
- Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
- University Hospitals Leuven, Department of Human Genetics, Catholic University of Leuven, Leuven, Belgium.
- Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
Förderung
- NIMH NIH HHS
- NICHD NIH HHS
- NIGMS NIH HHS
- Texas A&M University Health Science Center
- Fonds Wetenschappelijk Onderzoek
- Università degli Studi di Parma
- National Institutes of Health
- Universitat de Barcelona
Zitieren
APA
Freud, L. R., Galloway, S., Crowley, T. B., Moldenhauer, J., Swillen, A., Breckpot, J., Borrell, A., Vora, N. L., Cuneo, B., Hoffman, H., Gilbert, L., Nowakowska, B., Geremek, M., Kutkowska-Kaźmierczak, A., Vermeesch, J. R., Devriendt, K., Busa, T., Sigaudy, S., Vigneswaran, T., …, & Bassett, A. S. (2024). Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age. American Journal of Obstetrics and Gynecology, 230(3), 368.e1-368.e12. https://doi.org/10.1016/j.ajog.2023.09.005
Vancouver
Freud LR, Galloway S, Crowley TB, Moldenhauer J, Swillen A, Breckpot J, et al. Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age. American Journal of Obstetrics and Gynecology. 2024;230(3):368.e1-368.e12. doi:10.1016/j.ajog.2023.09.005
BibTeX
@article{Freud2024,
author = {Freud, Lindsay R and Galloway, Stephanie and Crowley, T Blaine and Moldenhauer, Julie and Swillen, Ann and Breckpot, Jeroen and Borrell, Antoni and Vora, Neeta L and Cuneo, Bettina and Hoffman, Hilary and Gilbert, Lisa and Nowakowska, Beata and Geremek, Maciej and Kutkowska-Kaźmierczak, Anna and Vermeesch, Joris R and Devriendt, Koen and Busa, Tiffany and Sigaudy, Sabine and Vigneswaran, Trisha and Simpson, John M and Dungan, Jeffrey and Gotteiner, Nina and Gloning, Karl-Philipp and Digilio, Maria Cristina and Unolt, Marta and Putotto, Carolina and Marino, Bruno and Repetto, Gabriela and Fadic, Magdalena and Garcia-Minaur, Sixto and Achón Buil, Ana and Thomas, Mary Ann and Fruitman, Deborah and Beecroft, Taylor and Hui, Pui Wah and Oskarsdottir, Solveig and Bradshaw, Rachael and Criebaum, Amanda and Norton, Mary E and Lee, Tiffany and Geiger, Miwa and Dunnington, Leslie and Isaac, Jacqueline and Wilkins-Haug, Louise and Hunter, Lindsey and Izzi, Claudia and Toscano, Marika and Ghi, Tullio and McGlynn, Julie and Romana Grati, Francesca and Emanuel, Beverly S and Gaiser, Kimberly and Gaynor, J William and Goldmuntz, Elizabeth and McGinn, Daniel E and Schindewolf, Erica and Tran, Oanh and Zackai, Elaine H and Yan, Qi and Bassett, Anne S},
title = {Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age},
journal = {American Journal of Obstetrics and Gynecology},
year = {2024},
volume = {230},
number = {3},
pages = {368.e1--368.e12},
doi = {10.1016/j.ajog.2023.09.005}
}
EUVIMED